Roflumilast Cream 0.05%

roflumilast · Arcutis Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Roflumilast Cream 0.05%, covering 2025-12-10 to 2025-12-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic Dermatitis [Phase 2]

See pricing